Explore

Trendline Trendline
Vertex Pharmaceuticals to Participate in Goldman Sachs Healthcare Conference, Highlighting Industry Engagement

Vertex Pharmaceuticals to Participate in Goldman Sachs Healthcare Conference, Highlighting Industry Engagement

Vertex Pharmaceuticals to Participate in Goldman Sachs Healthcare Conference, Highlighting Industry Engagement
Trendline Trendline
Decoy Therapeutics Nominates Patricia Gauthier for Board of Directors to Enhance Antiviral Strategy

Decoy Therapeutics Nominates Patricia Gauthier for Board of Directors to Enhance Antiviral Strategy

Decoy Therapeutics Nominates Patricia Gauthier for Board of Directors to Enhance Antiviral Strategy
Trendline Trendline
Cocrystal Pharma Appoints James Sapirstein as CEO to Advance Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Advance Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Advance Antiviral Development
Trendline Trendline
Cocrystal Pharma Appoints James Sapirstein as CEO to Lead Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Lead Antiviral Development

Cocrystal Pharma Appoints James Sapirstein as CEO to Lead Antiviral Development
Trendline Trendline
Corrixr Therapeutics Appoints Hilary M. Malone as CEO to Drive Cancer Treatment Development

Corrixr Therapeutics Appoints Hilary M. Malone as CEO to Drive Cancer Treatment Development

Corrixr Therapeutics Appoints Hilary M. Malone as CEO to Drive Cancer Treatment Development
Trendline Trendline
Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development

Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development

Ardena Appoints Ariane de Ganck as Chief Scientific Officer to Enhance Drug Development
Trendline Trendline
Eli Lilly Partners with Haisco in $3 Billion Deal for Early-Stage Drug Development

Eli Lilly Partners with Haisco in $3 Billion Deal for Early-Stage Drug Development

Eli Lilly Partners with Haisco in $3 Billion Deal for Early-Stage Drug Development
Trendline Trendline
hVIVO Partners with Decoy Therapeutics for Antiviral Development Consultancy

hVIVO Partners with Decoy Therapeutics for Antiviral Development Consultancy

hVIVO Partners with Decoy Therapeutics for Antiviral Development Consultancy
Trendline Trendline
Eli Lilly Partners with Ascidian Therapeutics for $1.9 Billion RNA Exon Editing Deal Targeting Kidney Diseases

Eli Lilly Partners with Ascidian Therapeutics for $1.9 Billion RNA Exon Editing Deal Targeting Kidney Diseases

Eli Lilly Partners with Ascidian Therapeutics for $1.9 Billion RNA Exon Editing Deal Targeting Kidney Diseases
Trendline Trendline
Incyte and Genesis Expand AI Collaboration to Over $1 Billion for Drug Discovery

Incyte and Genesis Expand AI Collaboration to Over $1 Billion for Drug Discovery

Incyte and Genesis Expand AI Collaboration to Over $1 Billion for Drug Discovery
Trendline Trendline
Vertex Pharmaceuticals to Engage in Goldman Sachs Global Healthcare Conference with CEO Fireside Chat

Vertex Pharmaceuticals to Engage in Goldman Sachs Global Healthcare Conference with CEO Fireside Chat

Vertex Pharmaceuticals to Engage in Goldman Sachs Global Healthcare Conference with CEO Fireside Chat
Trendline Trendline
Phosphorex Appoints John Rigg as Chairman to Enhance Drug Delivery Expertise

Phosphorex Appoints John Rigg as Chairman to Enhance Drug Delivery Expertise

Phosphorex Appoints John Rigg as Chairman to Enhance Drug Delivery Expertise